Select Page

Webinars and Podcasts

Fibrinogen Supplementation in Hemorrhagic Shock: Role of INTERCEPT® Fibrinogen Complex

Availability of fibrinogen sources (such as cryoprecipitated Antihemophilic Factor, cryo AHF) can be challenging given their long wait times and short shelf life. Timely administration of fibrinogen and other key clotting factors is essential to controlling hemorrhage associated with fibrinogen deficiency.  This workshop describes the importance of fibrinogen supplementation during hemorrhagic shock resuscitation, the University of Miami’s early experience with INTERCEPT® Fibrinogen Complex (IFC) and how IFC improves blood availability.

Presented by:
Jonathan P. Meizoso, MD, MSPH, FACS
Assistant Professor of Surgery
University of Miami / Ryder Trauma Center
Miami, Florida

Dr. Meizoso is a trauma and acute care surgeon and scientist at the University of Miami / Jackson Memorial Hospital’s Ryder Trauma Center in Miami, FL. He completed his undergraduate, medical school, and public health training at the University of Miami and his general surgery residency at Jackson Memorial Hospital. He then went on to pursue fellowships in surgical critical care, trauma, and acute care surgery at the Ernest E. Moore Shock Trauma Center at Denver Health and the University of Colorado. He is board certified in both general surgery and surgical critical care by the American Board of Surgery.

Dr. Meizoso’s clinical and research interests focus on the detection and management of patients in hemorrhagic shock, including damage control resuscitation and massive transfusion protocols, as well as trauma-induced coagulopathy, and viscoelastic testing.

Watch the Replay
Runtime: 19 min